This caught your eye...
Preview text: Ready to invest in your hair?
Using this email in an article? Credit: Salt Grooming email via They Sent It, with a link to this page. Full-size image
- Subject
- This caught your eye...
- Preview text
- Ready to invest in your hair?
- From
- contact@
saltgrooming.com - Brand
- Salt Grooming
- ESP
- Klaviyo
- Sent
- Sat Oct 3, 2026, 11:21 AM ET
- Size
- 43 KB
- Images
- 7
- Links
- 10, 1 of them buttons
- Subject length
- 23 characters
Against Salt Grooming's usual
Sent in the 11 AM hour, which holds 4% of its emails; 19% arrive in the 5 AM hour. The subject is 23 characters; its average is 28.
Email headers
What the brand's servers put on this email. Our receiving servers, the address we subscribed with and unsubscribe links are left out.
- From
- Salt Grooming <[email protected]>
- Subject
- This caught your eye...
- Date
- Sat, 03 Oct 2026 15:21:15 +0000 (UTC)
- Message-ID domain
- geopod-ismtpd-73
- Return-Path domain
- contact.saltgrooming.com
- DKIM signature
- d=saltgrooming.com s=kl2
- List-Unsubscribe
- Present, one-click
Servers it passed through, newest first
- by recvd-…-88dhp with SMTP
- from (unnamed) by geopod-ismtpd-73 with HTTP
Other sending headers (names only): X-Kmail-Account, X-Kmail-Flow, X-Kmail-Message, X-Kmail-Ops, X-Report-Abuse, X-SG-EID, X-SG-ID, X-Entity-ID
Sent just before and after
| Oct 5, 2026 2:30 PM | Settling the hair wash debate | |
| Oct 5, 2026 11:23 AM | Low stock alert [10% OFF inside] | |
| Oct 4, 2026 11:22 AM | Your hair deserves better... | |
| Oct 3, 2026 11:21 AM | This caught your eye... (this email) | |
| Oct 2, 2026 11:20 AM | Selling fast. Secure your product | |
| Oct 2, 2026 6:00 AM | We're going global... | |
| Sep 29, 2026 4:31 AM | Your restock just got cheaper |
More from Salt Grooming
All Salt Grooming emailsNov 5, 2026 2:01 PM
Will you still be using it in February?
Nov 2, 2026 6:00 AM
Oct 31, 2026 6:15 AM
Oct 29, 2026 3:30 PM
Oct 28, 2026 5:30 AM
Oct 25, 2026 3:30 PM
Buying the wrong products is expensive
Oct 22, 2026 2:01 PM
A clinically proven breakthrough
Oct 16, 2026 6:00 AM
